Instil Bio Inc (TIL)
10.44
-0.06
(-0.57%)
USD |
NASDAQ |
Jun 14, 16:00
10.45
+0.01
(+0.10%)
After-Hours: 20:00
Instil Bio Enterprise Value: -4.211M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | -4.211M |
| June 13, 2024 | -3.821M |
| June 12, 2024 | -2.13M |
| June 11, 2024 | -1.610M |
| June 10, 2024 | -4.016M |
| June 07, 2024 | -2.520M |
| June 06, 2024 | -2.696M |
| June 05, 2024 | -2.780M |
| June 04, 2024 | -2.780M |
| June 03, 2024 | -0.5691M |
| May 31, 2024 | -2.585M |
| May 30, 2024 | -0.3089M |
| May 29, 2024 | -3.171M |
| May 28, 2024 | -0.8293M |
| May 24, 2024 | -0.3395M |
| May 23, 2024 | 0.9918M |
| May 22, 2024 | 0.8618M |
| May 21, 2024 | 0.5574M |
| May 20, 2024 | 2.293M |
| May 17, 2024 | 2.683M |
| May 16, 2024 | 4.634M |
| May 15, 2024 | 6.585M |
| May 14, 2024 | 5.154M |
| May 13, 2024 | 4.634M |
| May 10, 2024 | 3.203M |
| Date | Value |
|---|---|
| May 09, 2024 | 0.9268M |
| May 08, 2024 | 1.122M |
| May 07, 2024 | 1.057M |
| May 06, 2024 | 2.943M |
| May 03, 2024 | 1.382M |
| May 02, 2024 | 0.8618M |
| May 01, 2024 | -2.390M |
| April 30, 2024 | -1.740M |
| April 29, 2024 | -3.984M |
| April 26, 2024 | -3.171M |
| April 25, 2024 | -4.471M |
| April 24, 2024 | -2.455M |
| April 23, 2024 | -2.195M |
| April 22, 2024 | -2.455M |
| April 19, 2024 | -2.910M |
| April 18, 2024 | -4.406M |
| April 17, 2024 | -3.268M |
| April 16, 2024 | -4.927M |
| April 15, 2024 | -4.211M |
| April 12, 2024 | -1.252M |
| April 11, 2024 | -0.1789M |
| April 10, 2024 | -1.089M |
| April 09, 2024 | -1.154M |
| April 08, 2024 | -1.350M |
| April 05, 2024 | 0.4715M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-177.97M
Minimum
Dec 27 2022
3.228B
Maximum
Mar 26 2021
610.28M
Average
176.34M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.382M |
| Palatin Technologies Inc | 19.39M |
| iBio Inc | 30.46M |
| Theriva Biologics Inc | -10.87M |
| Oragenics Inc | 6.996M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -24.30M |
| Total Expenses (Quarterly) | 19.68M |
| EPS Diluted (Quarterly) | -3.74 |
| Earnings Yield | -181.4% |